Integrating AI in Postural Rehabilitation for Parkinson's Disease
Efficacy of Integrating Artificial Intelligence Solutions in Rehabilitation in Postural Trunk Disorders in Parkinson's Disease.
1 other identifier
interventional
20
1 country
1
Brief Summary
Postural abnormalities are highly disabling complications of Parkinson's disease (PD). These include camptocormia, anterocollis, and Pisa Syndrome (PS). PS is characterized by a lateral trunk flexion (LTF) typically exceeding 10 degrees, often accompanied by axial rotation, asymmetric shoulder positioning, and poor awareness of the postural alteration. This condition worsens during upright activities and improves in a supine position. Patients with PD and PS are characterized by more pronounced motor asymmetry, a disorganized trunk muscle activity, back pain, balance issues, and reduced quality of life compared to PD patients without postural disorders. Camptocormia, another disabling postural anomaly, involves an anterior trunk flexion that also improves when lying down. Both PS and camptocormia are challenging to treat, with limited and short-lasting benefits from current multidisciplinary approaches, including medication, physiotherapy, botulinum toxin injections, and transcranial direct current stimulation (tDCS). Given the limitations of traditional rehabilitation strategies, there is a growing need for innovative and personalized approaches. In this context, advanced technologies such as artificial intelligence (AI) offer new possibilities for home-based treatment. This study aims to evaluate the feasibility of using a real-time visual feedback system powered by AI as a complementary intervention following inpatient neurorehabilitation for PD patients with trunk postural disorders (PS or camptocormia). A secondary objective is to assess whether an AI-guided, personalized exercise program can help maintain improvements in posture, mobility, and quality of life in the medium term. By integrating quantitative and qualitative outcomes, this study seeks to fill a gap in the literature and explore the potential of AI-driven home rehabilitation to support long-term functional gains and foster greater independence and well-being in people with PD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Oct 2024
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
June 8, 2025
May 1, 2025
3.3 years
May 20, 2025
May 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
System Usability Scale (SUS)
System Usability Scale (SUS) (continuous variable, score ranging from 0 to 100, with higher scores indicating better perceived usability of the system)
Single evaluation after 6-8 weeks from intervention (T1)
Secondary Outcomes (8)
Static trunk cinematic analysis of movement
Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)
Dynamic trunk cinematic analysis of movement
Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)
Time Up and Go test
Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)
Inertial Gait Analysis
Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)
30 second chair stand test
Evaluation at baseline, 6-8 weeks from baseline (T1) and 4 weeks from T1 (T2)
- +3 more secondary outcomes
Study Arms (1)
PD-Subjects
EXPERIMENTALSubjects with Parkinson's Disease and postural disorders (Pisa syndrome or camptocormia).
Interventions
AI-based home rehabilitation for postural disorders by means of the Kemtai platform.
Eligibility Criteria
You may qualify if:
- Age above 18 years
- Diagnosis of Parkinson's disease according to MDS criteria
- Hoehn and Yahr stage ≤ III
- Clinical diagnosis of camptocormia (presence of an anterior axial trunk flexion of at least 30°), or of Pisa Syndrome (presence of a lateral trunk flexion of at least 10°) at the time of enrollment (T0)
- Mini-Mental State Examination (MMSE) score \> 23
You may not qualify if:
- Atypical parkinsonian syndromes
- History of spinal surgery
- Previous vertebral trauma
- Current or past spinal tumors or infections
- Idiopathic scoliosis
- Ankylosing spondylitis
- Spinal canal stenosis
- Other neurological conditions
- Severe dyskinesias
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Mondino Foundation
Pavullo nel Frignano, Pavia, 27100, Italy
Related Publications (3)
Hoshiyama M, Kaneoke Y, Koike Y, Takahashi A, Watanabe S. Hypokinesia of associated movement in Parkinson's disease: a symptom in early stages of the disease. J Neurol. 1994 Aug;241(9):517-21. doi: 10.1007/BF00873512.
PMID: 7798998BACKGROUNDFasano A, Geroin C, Berardelli A, Bloem BR, Espay AJ, Hallett M, Lang AE, Tinazzi M. Diagnostic criteria for camptocormia in Parkinson's disease: A consensus-based proposal. Parkinsonism Relat Disord. 2018 Aug;53:53-57. doi: 10.1016/j.parkreldis.2018.04.033. Epub 2018 May 8.
PMID: 29759930BACKGROUNDDoherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay JP, Gershanik OS, Bloem BR. Postural deformities in Parkinson's disease. Lancet Neurol. 2011 Jun;10(6):538-49. doi: 10.1016/S1474-4422(11)70067-9. Epub 2011 Apr 22.
PMID: 21514890BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luca Martinis
IRCCS Mondino Foundation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2025
First Posted
June 8, 2025
Study Start
October 1, 2024
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
June 8, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
The final anonymized database will be uploaded in the Zenodo platform.